Posted by: Salvatore J. Zambri, Esquire
According to an AP (9/16) report, Pharmacia and Upjohn, a subsidiary of Pfizer, “has pleaded guilty to illegally promoting the pain killer Bextra [valdecoxib]” as part of “a settlement agreement announced earlier this month, when prosecutors slapped” Pfizer “with a record-breaking $2.3 billion in fines for illegal drug promotions.” In addition, Bloomberg News (9/16, O’Reilly) reports that, according to the United States Department of Justice, “US District Judge Douglas P. Woodlock in Boston took the plea…but deferred a decision on formally accepting it until a sentencing hearing on Oct. 16.”
All too often we hear about drug companies, insurers, and other entities that put profits over people. Innovation is essential, but no company should ever seek money at the expense of public health and well-being. Such conduct is reprehensible and dangerous. Access to justice through the civil jury system is what allows for proper checks and balances. If gives people a fair voice to speak out against corporate corruption, and it allows the innocent victims of corporate greed to obtain fair and just compensation for all of their harms and losses.
About the author:
Mr. Zambri has been rated by Washingtonian magazine as a “Big Gun” and among the “top 1%” of all lawyers in the Washington metropolitan area. The magazine also describes him as “one of Washington’s best–most honest and effective lawyers” who specializes in personal injury matters, including medical malpractice actions. He has also been named a “DC Super Lawyer” by Super Lawyer magazine (March/April 2009)–a national publication that honors the top lawyers in America. Our firm has experience pursing cases for patients that involve dangerous medical products. If you need a patient advocate, we recommend that you read an article about medical malpractice claims authored by senior partner Salvatore Zambri.
If you want more information about your legal rights, please email Mr. Zambri at firstname.lastname@example.org or call him at 202-822-1899.